CN-6000 Automated Blood Coagulation Analyzer From Sysmex Gets FDA Clearance
Sysmex America has received FDA clearance for its CN-6000 Automated Blood Coagulation Analyzer and key hemostasis test reagents.
Tag: urinalysis
All
Latest
All
Latest
CLP March/April 2024 Tech Guide: Urinalysis
The CLP March/April 2024 Tech Guide in Clinical Lab Products (CLP) showcases a diverse array of products from seven laboratory providers.
All
Latest
New Test Aids Cystic Fibrosis Patients
Researchers developed a urine test to measure the severity of the serious disease cystic fibrosis and assess the effect of new treatments.
Essenlix, Roche Norway Wins for Patient At-Home Testing Solution
Essenlix Corporation, in partnership with Roche Norway, has won Norway Østfold Hospital System’s “Patient At-Home Test” Innovation Partnership.
Read More
Prostate Cancer Urine Test Identifies Good Prognosis Patients
A prostate cancer urine test can identify men at intermediate risk who can safely avoid immediate treatment and benefit from active surveillance instead.
Read More
Building a Better Dipstick Test
A research team from Georgia Tech has developed flow control technology to turn simple lateral flow assays into complex biomedical assays.
Read More
Toxicology Testing: Addressing the Epidemic within the Pandemic
Timely toxicology testing remains vital to patient treatment, but the challenge is staying ahead of emerging illicit drugs.
Read More
Sysmex America Launches Automated Hematology Analyzer for Malaria Detection
Diagnostics company Sysmex America has launched a hemotology analyzer that has the ability to detect malaria.
Read More
Beckman Coulter Introduces DxU Iris Workcell for Urinalysis
Beckman Coulter launched its DxU Iris Workcell today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo in Atlanta.
Read More
Urine DNA Test Detects Bladder Cancer Data Shows
Promis Diagnostics recently presented data for CystoChek, a proprietary urine-based DNA methylation test of PENK for bladder cancer detection in hematuria.
Read More
Sysmex America Names Andy Hay CEO
Sysmex America, Inc., has announced that Ralph Taylor, the company’s CEO, will retire effective September 30, 2021, and will be succeed by COO Andy Hay.
Read More
Blood and Urine Tests Could Speed Diagnosis of Tumors
Blood and urine tests could lead to faster and less invasive methods to diagnose and monitor various types of tumors, new research indicates.
Read More
Self-Powered Diaper Sensors Monitor Urine Sugar Levels
To measure urine sugar levels in elderly or long-term care patients, sensors can be embedded directly into their diapers.
Read More
Is Preoperative Screening Urinalysis Needed? Study Says, ‘No’
Patients undergoing surgery and other procedures are routinely pre-screened for UTIs, but the vast majority of these tests are not needed.
Read More
AnchorDx UriFind Bladder Cancer Test Gets FDA Breakthrough Device Designation
The FDA awarded AnchorDx a Breakthrough Device Designation for UriFind, an early detection test for bladder cancer based on urine DNA methylation detection.
Read More
A Noninvasive Urine Test Can Detect Cancer Cells
MIT engineers have created a diagnostic nanoparticle that can identify cancer through a urine test and act as an imaging agent, pinpointing the tumor location.
Read More
Birmingham University, Nonacus Partner to Develop Urine Test for Bladder Cancer
The urine test, which is expected to be available by mid-2022, will use highly sensitive liquid biopsy technology developed by Nonacus and a panel of biomarkers validated by Birmingham University researchers to diagnose bladder cancer.
Read More
Urine Test May Aid Early Detection of Brain Tumors
A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumors.
Read More